ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Abramson Cancer Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Abramson Cancer Center takes part in 5 sessions at ESMO 2026 in Madrid. Its work focuses on treatment and outcomes in ovarian and bladder cancers. It examines azenosertib for platinum-resistant ovarian cancer and bladder-intact survival as a measure of longer-term outcomes.

OrganizationESMO 2026 Attendance
Abramson Cancer Center
Philadelphia, PA
Cancer centre & hospital
US National Cancer Institute-designated comprehensive cancer centre of the University of Pennsylvania and Penn Medicine in Philadelphia, Pennsylvania.
Abstract
Fri Oct 23
16:47–16:52
Abstract
Sun Oct 25
09:00–09:12
Invited Discussant 3586O, 3587O and LBA88
Proffered paper 2: Genitourinary tumours, renal and urothelial
Genitourinary cancers
Poster
Mon Oct 26
12:00–12:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Abramson Cancer Center

Tell us what you sell and we’ll find the people at Abramson Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction